Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Job: Deputy Chief Compliance Officer

Job Title: Deputy Chief Compliance Officer

Employer: Orthofix

Location: Lewisville, Texas USA

Description: The Deputy Chief Compliance Officer will be responsible for the development, enhancement and consistent implementation of the global compliance program and improving Orthofix’s internal controls and processes designed to detect and prevent acts of corruption and fraud.… Continue Reading

SEC charges Orthofix with FCPA violations in Brazil

The SEC Wednesday charged Texas-based medical device maker Orthofix International with violating the Foreign Corrupt Practices Act when its subsidiary in Brazil made improper payments to doctors at government-owned hospitals to increase sales.… Continue Reading

Job: Corporate Compliance Manager (Orthofix Inc. – Lewisville, TX)

Job Title: Corporate Compliance Manager

Employer: Orthofix Inc.

Location:  Lewisville, Texas, United States

 

POSITION SUMMARY: The Corporate Compliance Manager will assist the Chief Compliance Officer (“CCO”) or the CCO’s designee in managing, developing and implementing various compliance initiatives for the BioStim strategic business unit (“SBU”) and other Orthofix SBUs.… Continue Reading

Job: Compliance Manager (Orthofix)

Job Title: Corporate Compliance Manager

Employer: Orthofix Inc.

Location: Lewisville, Texas USA

 

Description

The Corporate Compliance Manager will assist the Chief Compliance Officer (“CCO”) or the CCO’s designee in developing and implementing various domestic and international compliance initiatives, focusing primarily on policies and procedures and training and education, but also including auditing and monitoring, with the objective of facilitating and maintaining an effective Corporate Compliance Program and ensuring the company’s continued compliance with the domestic Corporate Integrity Agreement and the FCPA settlement.… Continue Reading

U.S., China enforcement crossfire creates new risks

At the beginning of this year, China’s president Xi Jinping promised to fight both “tigers” and “flies” — high-ranking and low-ranking corrupt officials — in his crackdown on corruption. Since then, the anti-graft campaign has led to the conviction of Bo Xilai and to the front-page investigations of foreign companies in the pharmaceutical and oil and gas sectors, among others.… Continue Reading

Enforcement Report for Q3 ’12

During the quarter just ended, there were five corporate FCPA enforcement actions, one enforcement against an individual by the SEC, four criminal sentencings of individuals, and three and a half corporate declinations.… Continue Reading

Orthofix Pays $7.4 Million To Settle Mexico Bribes

Texas-based medical device company Orthofix International N.V. settled FCPA charges today relating to bribes in Mexico.

The company agreed to pay the SEC $5.2 million, including $4.98 million in disgorgement and $242,000 in prejudgment interest.… Continue Reading